Politicizing the FDA: What the Trump Win Means for New Pharma ...
Regulatory Focus-11 hours ago
... pointed to recent guidance documents on biosimilars and drug compounding as examples of overdue documents that clarify how laws are to be implemented.
No comments:
Post a Comment